English

KOS PHARMACEUTICALS INC

EDGAR

Quarterly report (10-Q) · filed 2006-11-09

47 filing records in this dataset, filed from 1997-05-15 to 2006-11-09. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

241 million USD

2006-09-30 · USD

Exact inputs and evidence

Revenue: 240933000 USD Source

Operating margin

21.1%

2006-09-30 · %

Exact inputs and evidence

Operating Income: 50827000 USD Source
Revenue: 240933000 USD Source

Operating cash flow

67.8 million USD

2006-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: 107196000 USD Source
Operating Cash Flow: 39391000 USD Source

Cash and cash equivalents: 542 million USD 2006-09-30 Source
Exact value

542493000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Operating cash flow

203 million USD

2005-10-01 – 2006-09-30

Exact inputs and evidence

Operating cash flow: 237496000 USD · 2005-01-01 – 2005-12-31 Source
Operating cash flow: 141659000 USD · 2005-01-01 – 2005-09-30 Source
Operating cash flow: 18846000 USD · 2006-01-01 – 2006-03-31 Source
Operating cash flow: 39391000 USD · 2006-01-01 – 2006-06-30 Source
Operating cash flow: 18846000 USD · 2006-01-01 – 2006-03-31 Source
Operating cash flow: 107196000 USD · 2006-01-01 – 2006-09-30 Source
Operating cash flow: 39391000 USD · 2006-01-01 – 2006-06-30 Source

Capital expenditure

1.46 million USD

2000-07-01 – 2001-06-30

Exact inputs and evidence

Capital expenditure: 545000 USD · 2000-01-01 – 2000-09-30 Source
Capital expenditure: 436000 USD · 2000-01-01 – 2000-06-30 Source
Capital expenditure: 638252 USD · 2000-01-01 – 2000-12-31 Source
Capital expenditure: 545000 USD · 2000-01-01 – 2000-09-30 Source
Capital expenditure: 205000 USD · 2001-01-01 – 2001-03-31 Source
Capital expenditure: 1255000 USD · 2001-01-01 – 2001-06-30 Source
Capital expenditure: 205000 USD · 2001-01-01 – 2001-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2006-11-09.

Financial data available through: 2005-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2005-12-31
Operating income: 11 of 11 periods available· newest 2005-12-31
Net income: 11 of 11 periods available· newest 2005-12-31
Operating cash flow: 11 of 11 periods available· newest 2005-12-31
Capital expenditure: 8 of 11 periods available· newest 2000-12-31
Total assets: 11 of 11 periods available· newest 2005-12-31
Total liabilities: 3 of 11 periods available· newest 2004-12-31
Current assets: 11 of 11 periods available· newest 2005-12-31
Current liabilities: 11 of 11 periods available· newest 2005-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2005-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+51.2%

Prior period

USD 497.1 million

2004-01-01 – 2004-12-31
Current period

USD 751.7 million

2005-01-01 – 2005-12-31

Exact inputs and evidence

751700000 − 497103000 = 254597000 USD

497103000 USD · 2004-01-01 – 2004-12-31
Inspect prior input Prior source
751700000 USD · 2005-01-01 – 2005-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · KOS PHARMACEUTICALS INC · 2005-12-31 KOS PHARMACEUTICALS INC (edgar:1018952) Year-over-year change in Revenue: 254597000 USD Concept: fundies:Revenue Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1018952?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 751700000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1018952/0000950144-06-008796.txt#11290 Input fundies:Revenue: 497103000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1018952/0000950144-06-008796.txt#11290
The citation records this snapshot. The page link may show a newer release later.
Net income
-21.2%

Prior period

USD 144.84 million

2004-01-01 – 2004-12-31
Current period

USD 114.08 million

2005-01-01 – 2005-12-31

Exact inputs and evidence

114075000 − 144840000 = -30765000 USD

144840000 USD · 2004-01-01 – 2004-12-31
Inspect prior input Prior source
114075000 USD · 2005-01-01 – 2005-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · KOS PHARMACEUTICALS INC · 2005-12-31 KOS PHARMACEUTICALS INC (edgar:1018952) Year-over-year change in Net income: -30765000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1018952?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 114075000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1018952/0000950144-06-008796.txt#13633 Input fundies:NetIncome: 144840000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1018952/0000950144-06-008796.txt#13633
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+21%

Prior period

USD 196.35 million

2004-01-01 – 2004-12-31
Current period

USD 237.5 million

2005-01-01 – 2005-12-31

Exact inputs and evidence

237496000 − 196354000 = 41142000 USD

196354000 USD · 2004-01-01 – 2004-12-31
Inspect prior input Prior source
237496000 USD · 2005-01-01 – 2005-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · KOS PHARMACEUTICALS INC · 2005-12-31 KOS PHARMACEUTICALS INC (edgar:1018952) Year-over-year change in Operating cash flow: 41142000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1018952?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 237496000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1018952/0000950144-06-008796.txt#14082 Input fundies:OperatingCashFlow: 196354000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1018952/0000950144-06-008796.txt#14082
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2005 2005-01-01 – 2005-12-31

Revenue USD 751.7 million 100% of revenue
Operating costs Derived USD 576.54 million 77% of revenue
Operating income USD 175.16 million 23% of revenue
Tax, interest and other Derived USD 61.08 million 8.1% of revenue
Net income USD 114.08 million 15% of revenue

Cash

Operating cash flow USD 237.5 million 32% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1997 Not shown: operating income or net income is not reported.
1997 Operating loss: operating costs were 1,571% of revenue.
1998 Operating loss: operating costs were 720% of revenue.
1999 Operating loss: operating costs were 242% of revenue.
2000 Operating loss: operating costs were 148% of revenue.
2001 Operating loss: operating costs were 134% of revenue.
2002 Operating loss: operating costs were 110% of revenue.
2003 18%80%
2004 Net income was higher than operating income, so the split is not drawn.
2005 15%77%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1997 1996-07-01 – 1997-06-30	0	Unavailable	Unavailable	Unavailable	-23121370	-21134655 Derived	Source 1996-07-01 – 1997-06-30: 0 USD Inspect Revenue Open source 1996-07-01 – 1997-06-30: -23121370 USD Inspect Net Income Open source 1996-07-01 – 1997-06-30: -19135440 USD Inspect Operating Cash Flow Open source 1996-07-01 – 1997-06-30: 1999215 USD Inspect Capital Expenditure Open source
1997 1997-01-01 – 1997-12-31	2892065	45431100 Derived	-42539035	-1909054 Derived	-40629981	-45457054 Derived	Source 1997-01-01 – 1997-12-31: 2892065 USD Inspect Revenue Open source 1997-01-01 – 1997-12-31: -42539035 USD Inspect Operating Income Open source 1997-01-01 – 1997-12-31: -40629981 USD Inspect Net Income Open source 1997-01-01 – 1997-12-31: -40241027 USD Inspect Operating Cash Flow Open source 1997-01-01 – 1997-12-31: 5216027 USD Inspect Capital Expenditure Open source
1998 1998-01-01 – 1998-12-31	13038241	93939194 Derived	-80900953	-1739511 Derived	-79161442	-75006346 Derived	Source 1998-01-01 – 1998-12-31: 13038241 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: -80900953 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: -79161442 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: -68130005 USD Inspect Operating Cash Flow Open source 1998-01-01 – 1998-12-31: 6876341 USD Inspect Capital Expenditure Open source
1999 1999-01-01 – 1999-12-31	36339514	87868017 Derived	-51528503	3023724 Derived	-54552227	-53093445 Derived	Source 1999-01-01 – 1999-12-31: 36339514 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: -51528503 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: -54552227 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: -51975808 USD Inspect Operating Cash Flow Open source 1999-01-01 – 1999-12-31: 1117637 USD Inspect Capital Expenditure Open source
2000 2000-01-01 – 2000-12-31	60173940	89222257 Derived	-29048317	6216705 Derived	-35265022	-30891688 Derived	Source 2000-01-01 – 2000-12-31: 60173940 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -29048317 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: -35265022 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: -30253436 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 638252 USD Inspect Capital Expenditure Open source
2001 2001-01-01 – 2001-12-31	91447043	122207318 Derived	-30760275	-33146516 Derived	2386241	Unavailable	Source 2001-01-01 – 2001-12-31: 91447043 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -30760275 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: 2386241 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: 7102255 USD Inspect Operating Cash Flow Open source
2002 2002-01-01 – 2002-12-31	172692718	189487266 Derived	-16794548	4021616 Derived	-20816164	Unavailable	Source 2002-01-01 – 2002-12-31: 172692718 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -16794548 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: -20816164 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: -1237038 USD Inspect Operating Cash Flow Open source
2003 2003-01-01 – 2003-12-31	293907000	235946000 Derived	57961000	5783000 Derived	52178000	Unavailable	Source 2003-01-01 – 2003-12-31: 293907000 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: 57961000 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: 52178000 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: 55610000 USD Inspect Operating Cash Flow Open source
2004 2004-01-01 – 2004-12-31	497103000	386566000 Derived	110537000	-34303000 Derived	144840000	Unavailable	Source 2004-01-01 – 2004-12-31: 497103000 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: 110537000 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: 144840000 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: 196354000 USD Inspect Operating Cash Flow Open source
2005 2005-01-01 – 2005-12-31	751700000	576543000 Derived	175157000	61082000 Derived	114075000	Unavailable	Source 2005-01-01 – 2005-12-31: 751700000 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: 175157000 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: 114075000 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: 237496000 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 751.7M 2005

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19971997-06-30	Revenue	0	Revenue: 0 Open source
19971997-12-31	Revenue	2892065	Revenue: 2892065 Open source
19981998-12-31	Revenue	13038241	Revenue: 13038241 Open source
19991999-12-31	Revenue	36339514	Revenue: 36339514 Open source
20002000-12-31	Revenue	60173940	Revenue: 60173940 Open source
20012001-12-31	Revenue	91447043	Revenue: 91447043 Open source
20022002-12-31	Revenue	172692718	Revenue: 172692718 Open source
20032003-12-31	Revenue	293907000	Revenue: 293907000 Open source
20042004-12-31	Revenue	497103000	Revenue: 497103000 Open source
20052005-12-31	Revenue	751700000	Revenue: 751700000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

51.2% 2005

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19971997-06-30	Year over year	No prior comparable period	Revenue: 0 Open source
19971997-12-31	Year over year	No prior comparable period	Revenue: 2892065 Open source Revenue: 0 Open source
19981998-12-31	Year over year	350.8%	Revenue: 13038241 Open source Revenue: 2892065 Open source
19991999-12-31	Year over year	178.7%	Revenue: 36339514 Open source Revenue: 13038241 Open source
20002000-12-31	Year over year	65.6%	Revenue: 60173940 Open source Revenue: 36339514 Open source
20012001-12-31	Year over year	52%	Revenue: 91447043 Open source Revenue: 60173940 Open source
20022002-12-31	Year over year	88.8%	Revenue: 172692718 Open source Revenue: 91447043 Open source
20032003-12-31	Year over year	70.2%	Revenue: 293907000 Open source Revenue: 172692718 Open source
20042004-12-31	Year over year	69.1%	Revenue: 497103000 Open source Revenue: 293907000 Open source
20052005-12-31	Year over year	51.2%	Revenue: 751700000 Open source Revenue: 497103000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 23.3% 2005

Net margin 15.2% 2005

Free cash flow margin -51.3% 2000

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
1997-06-30	Operating margin	Not reported	Revenue: 0 Open source
19971997-12-31	Operating margin	-1,470.9%	Operating Income: -42539035 Open source Revenue: 2892065 Open source
19981998-12-31	Operating margin	-620.5%	Operating Income: -80900953 Open source Revenue: 13038241 Open source
19991999-12-31	Operating margin	-141.8%	Operating Income: -51528503 Open source Revenue: 36339514 Open source
20002000-12-31	Operating margin	-48.3%	Operating Income: -29048317 Open source Revenue: 60173940 Open source
20012001-12-31	Operating margin	-33.6%	Operating Income: -30760275 Open source Revenue: 91447043 Open source
20022002-12-31	Operating margin	-9.7%	Operating Income: -16794548 Open source Revenue: 172692718 Open source
20032003-12-31	Operating margin	19.7%	Operating Income: 57961000 Open source Revenue: 293907000 Open source
20042004-12-31	Operating margin	22.2%	Operating Income: 110537000 Open source Revenue: 497103000 Open source
20052005-12-31	Operating margin	23.3%	Operating Income: 175157000 Open source Revenue: 751700000 Open source
19971997-06-30	Net margin	Not reported	Net Income: -23121370 Open source Revenue: 0 Open source
19971997-12-31	Net margin	-1,404.9%	Net Income: -40629981 Open source Revenue: 2892065 Open source
19981998-12-31	Net margin	-607.1%	Net Income: -79161442 Open source Revenue: 13038241 Open source
19991999-12-31	Net margin	-150.1%	Net Income: -54552227 Open source Revenue: 36339514 Open source
20002000-12-31	Net margin	-58.6%	Net Income: -35265022 Open source Revenue: 60173940 Open source
20012001-12-31	Net margin	2.6%	Net Income: 2386241 Open source Revenue: 91447043 Open source
20022002-12-31	Net margin	-12.1%	Net Income: -20816164 Open source Revenue: 172692718 Open source
20032003-12-31	Net margin	17.8%	Net Income: 52178000 Open source Revenue: 293907000 Open source
20042004-12-31	Net margin	29.1%	Net Income: 144840000 Open source Revenue: 497103000 Open source
20052005-12-31	Net margin	15.2%	Net Income: 114075000 Open source Revenue: 751700000 Open source
19971997-06-30	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -19135440 Open source Capital Expenditure: 1999215 Open source
19971997-12-31	Free cash flow margin	-1,571.8%	Revenue: 2892065 Open source Operating Cash Flow: -40241027 Open source Capital Expenditure: 5216027 Open source
19981998-12-31	Free cash flow margin	-575.3%	Revenue: 13038241 Open source Operating Cash Flow: -68130005 Open source Capital Expenditure: 6876341 Open source
19991999-12-31	Free cash flow margin	-146.1%	Revenue: 36339514 Open source Operating Cash Flow: -51975808 Open source Capital Expenditure: 1117637 Open source
20002000-12-31	Free cash flow margin	-51.3%	Revenue: 60173940 Open source Operating Cash Flow: -30253436 Open source Capital Expenditure: 638252 Open source
20012001-12-31	Free cash flow margin	Not reported	Revenue: 91447043 Open source Operating Cash Flow: 7102255 Open source
20022002-12-31	Free cash flow margin	Not reported	Revenue: 172692718 Open source Operating Cash Flow: -1237038 Open source
20032003-12-31	Free cash flow margin	Not reported	Revenue: 293907000 Open source Operating Cash Flow: 55610000 Open source
20042004-12-31	Free cash flow margin	Not reported	Revenue: 497103000 Open source Operating Cash Flow: 196354000 Open source
20052005-12-31	Free cash flow margin	Not reported	Revenue: 751700000 Open source Operating Cash Flow: 237496000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 237.5M 2005

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19971997-06-30	Operating cash flow	-19135440	Operating Cash Flow: -19135440 Open source
19971997-12-31	Operating cash flow	-40241027	Operating Cash Flow: -40241027 Open source
19981998-12-31	Operating cash flow	-68130005	Operating Cash Flow: -68130005 Open source
19991999-12-31	Operating cash flow	-51975808	Operating Cash Flow: -51975808 Open source
20002000-12-31	Operating cash flow	-30253436	Operating Cash Flow: -30253436 Open source
20012001-12-31	Operating cash flow	7102255	Operating Cash Flow: 7102255 Open source
20022002-12-31	Operating cash flow	-1237038	Operating Cash Flow: -1237038 Open source
20032003-12-31	Operating cash flow	55610000	Operating Cash Flow: 55610000 Open source
20042004-12-31	Operating cash flow	196354000	Operating Cash Flow: 196354000 Open source
20052005-12-31	Operating cash flow	237496000	Operating Cash Flow: 237496000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -30.9M 2000

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19971997-06-30	Free cash flow	-21134655	Operating Cash Flow: -19135440 Open source Capital Expenditure: 1999215 Open source
19971997-12-31	Free cash flow	-45457054	Operating Cash Flow: -40241027 Open source Capital Expenditure: 5216027 Open source
19981998-12-31	Free cash flow	-75006346	Operating Cash Flow: -68130005 Open source Capital Expenditure: 6876341 Open source
19991999-12-31	Free cash flow	-53093445	Operating Cash Flow: -51975808 Open source Capital Expenditure: 1117637 Open source
20002000-12-31	Free cash flow	-30891688	Operating Cash Flow: -30253436 Open source Capital Expenditure: 638252 Open source
20012001-12-31	Free cash flow	Unavailable	Operating Cash Flow: 7102255 Open source
20022002-12-31	Free cash flow	Unavailable	Operating Cash Flow: -1237038 Open source
20032003-12-31	Free cash flow	Unavailable	Operating Cash Flow: 55610000 Open source
20042004-12-31	Free cash flow	Unavailable	Operating Cash Flow: 196354000 Open source
20052005-12-31	Free cash flow	Unavailable	Operating Cash Flow: 237496000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

25.7% 2004

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1997-06-30	Liabilities / assets	Not reported	Total Assets: 65105000 Open source
19971997-12-31	Liabilities / assets	7.7%	Total Liabilities: 6533000 Open source Total Assets: 84403430 Open source
1998-12-31	Liabilities / assets	Not reported	Total Assets: 21570000 Open source
19991999-12-31	Liabilities / assets	302.6%	Total Liabilities: 79453000 Open source Total Assets: 26258107 Open source
2000-12-31	Liabilities / assets	Not reported	Total Assets: 29648323 Open source
2001-12-31	Liabilities / assets	Not reported	Total Assets: 82940803 Open source
2002-12-31	Liabilities / assets	Not reported	Total Assets: 69441000 Open source
2003-12-31	Liabilities / assets	Not reported	Total Assets: 335521171 Open source
20042004-12-31	Liabilities / assets	25.7%	Total Liabilities: 151784000 Open source Total Assets: 590059000 Open source
2005-12-31	Liabilities / assets	Not reported	Total Assets: 913855000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.86× 2005

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
19971997-06-30	Current assets / current liabilities	2.99×	Current Assets: 60080000 Open source Current Liabilities: 20093000 Open source
19971997-12-31	Current assets / current liabilities	11.86×	Current Assets: 77472234 Open source Current Liabilities: 6533572 Open source
19981998-12-31	Current assets / current liabilities	0.75×	Current Assets: 9534000 Open source Current Liabilities: 12670000 Open source
19991999-12-31	Current assets / current liabilities	0.86×	Current Assets: 15009559 Open source Current Liabilities: 17363516 Open source
20002000-12-31	Current assets / current liabilities	0.92×	Current Assets: 20826950 Open source Current Liabilities: 22738185 Open source
20012001-12-31	Current assets / current liabilities	1.59×	Current Assets: 73458180 Open source Current Liabilities: 46298225 Open source
20022002-12-31	Current assets / current liabilities	0.5×	Current Assets: 55481000 Open source Current Liabilities: 110125000 Open source
20032003-12-31	Current assets / current liabilities	4.76×	Current Assets: 313952358 Open source Current Liabilities: 65893766 Open source
20042004-12-31	Current assets / current liabilities	2.86×	Current Assets: 391008000 Open source Current Liabilities: 136788000 Open source
20052005-12-31	Current assets / current liabilities	2.86×	Current Assets: 602466000 Open source Current Liabilities: 210639000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1997 1996-07-01 – 1997-06-30	−USD 23.12 million Exact value Exact value: -23121370 USD 1996-07-01 – 1997-06-30: -23121370 USD Inspect Net Income Open source Share or cite Citation for Net Income · KOS PHARMACEUTICALS INC · 1997-06-30 KOS PHARMACEUTICALS INC (edgar:1018952) Net Income: -23121370 USD Concept: fundies:NetIncome Period: 1996-07-01 to 1997-06-30 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1018952/explain?concept=fundies%3ANetIncome&period=1997-06-30&surface=latest&period_type=duration&start=1996-07-01&unit=USD&dimensions= Input fundies:NetIncome: -23121370 USD (1996-07-01 to 1997-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1018952/0000950144-97-010186.txt#1890 The citation records this snapshot. The page link may show a newer release later.	−USD 19.14 million Exact value Exact value: -19135440 USD 1996-07-01 – 1997-06-30: -19135440 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KOS PHARMACEUTICALS INC · 1997-06-30 KOS PHARMACEUTICALS INC (edgar:1018952) Operating Cash Flow: -19135440 USD Concept: fundies:OperatingCashFlow Period: 1996-07-01 to 1997-06-30 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1018952/explain?concept=fundies%3AOperatingCashFlow&period=1997-06-30&surface=latest&period_type=duration&start=1996-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -19135440 USD (1996-07-01 to 1997-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1018952/0000950144-97-010186.txt#1907 The citation records this snapshot. The page link may show a newer release later.	USD 2 million Exact value Exact value: 1999215 USD 1996-07-01 – 1997-06-30: 1999215 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · KOS PHARMACEUTICALS INC · 1997-06-30 KOS PHARMACEUTICALS INC (edgar:1018952) Capital Expenditure: 1999215 USD Concept: fundies:CapitalExpenditure Period: 1996-07-01 to 1997-06-30 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1018952/explain?concept=fundies%3ACapitalExpenditure&period=1997-06-30&surface=latest&period_type=duration&start=1996-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1999215 USD (1996-07-01 to 1997-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1018952/0000950144-97-010186.txt#1912 The citation records this snapshot. The page link may show a newer release later.	−USD 21.13 million Calculation and evidence -19135440 − 1999215 USD Exact free cash flow: -21134655 USD 1996-07-01 – 1997-06-30: -19135440 USD · Inspect Operating Cash Flow · Source 1996-07-01 – 1997-06-30: 1999215 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · KOS PHARMACEUTICALS INC · 1997-06-30 KOS PHARMACEUTICALS INC (edgar:1018952) Free cash flow: -21134655 USD Concept: free-cash-flow Period: 1996-07-01 to 1997-06-30 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1018952?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -19135440 USD (1996-07-01 to 1997-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1018952/0000950144-97-010186.txt#1907 Input fundies:CapitalExpenditure: 1999215 USD (1996-07-01 to 1997-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1018952/0000950144-97-010186.txt#1912 The citation records this snapshot. The page link may show a newer release later.
1997 1997-01-01 – 1997-12-31	−USD 40.63 million Exact value Exact value: -40629981 USD 1997-01-01 – 1997-12-31: -40629981 USD Inspect Net Income Open source Share or cite Citation for Net Income · KOS PHARMACEUTICALS INC · 1997-12-31 KOS PHARMACEUTICALS INC (edgar:1018952) Net Income: -40629981 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1018952/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: -40629981 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1018952/0000950170-00-000407.txt#2189 The citation records this snapshot. The page link may show a newer release later.	−USD 40.24 million Exact value Exact value: -40241027 USD 1997-01-01 – 1997-12-31: -40241027 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KOS PHARMACEUTICALS INC · 1997-12-31 KOS PHARMACEUTICALS INC (edgar:1018952) Operating Cash Flow: -40241027 USD Concept: fundies:OperatingCashFlow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1018952/explain?concept=fundies%3AOperatingCashFlow&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -40241027 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1018952/0000950170-00-000407.txt#2207 The citation records this snapshot. The page link may show a newer release later.	USD 5.22 million Exact value Exact value: 5216027 USD 1997-01-01 – 1997-12-31: 5216027 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · KOS PHARMACEUTICALS INC · 1997-12-31 KOS PHARMACEUTICALS INC (edgar:1018952) Capital Expenditure: 5216027 USD Concept: fundies:CapitalExpenditure Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1018952/explain?concept=fundies%3ACapitalExpenditure&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5216027 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1018952/0000950170-00-000407.txt#2213 The citation records this snapshot. The page link may show a newer release later.	−USD 45.46 million Calculation and evidence -40241027 − 5216027 USD Exact free cash flow: -45457054 USD 1997-01-01 – 1997-12-31: -40241027 USD · Inspect Operating Cash Flow · Source 1997-01-01 – 1997-12-31: 5216027 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · KOS PHARMACEUTICALS INC · 1997-12-31 KOS PHARMACEUTICALS INC (edgar:1018952) Free cash flow: -45457054 USD Concept: free-cash-flow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1018952?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -40241027 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1018952/0000950170-00-000407.txt#2207 Input fundies:CapitalExpenditure: 5216027 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1018952/0000950170-00-000407.txt#2213 The citation records this snapshot. The page link may show a newer release later.
1998 1998-01-01 – 1998-12-31	−USD 79.16 million Exact value Exact value: -79161442 USD 1998-01-01 – 1998-12-31: -79161442 USD Inspect Net Income Open source Share or cite Citation for Net Income · KOS PHARMACEUTICALS INC · 1998-12-31 KOS PHARMACEUTICALS INC (edgar:1018952) Net Income: -79161442 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1018952/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: -79161442 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1018952/0000950170-01-000355.txt#2298 The citation records this snapshot. The page link may show a newer release later.	−USD 68.13 million Exact value Exact value: -68130005 USD 1998-01-01 – 1998-12-31: -68130005 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KOS PHARMACEUTICALS INC · 1998-12-31 KOS PHARMACEUTICALS INC (edgar:1018952) Operating Cash Flow: -68130005 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1018952/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -68130005 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1018952/0000950170-01-000355.txt#2316 The citation records this snapshot. The page link may show a newer release later.	USD 6.88 million Exact value Exact value: 6876341 USD 1998-01-01 – 1998-12-31: 6876341 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · KOS PHARMACEUTICALS INC · 1998-12-31 KOS PHARMACEUTICALS INC (edgar:1018952) Capital Expenditure: 6876341 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1018952/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6876341 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1018952/0000950170-01-000355.txt#2321 The citation records this snapshot. The page link may show a newer release later.	−USD 75.01 million Calculation and evidence -68130005 − 6876341 USD Exact free cash flow: -75006346 USD 1998-01-01 – 1998-12-31: -68130005 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 6876341 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · KOS PHARMACEUTICALS INC · 1998-12-31 KOS PHARMACEUTICALS INC (edgar:1018952) Free cash flow: -75006346 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1018952?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -68130005 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1018952/0000950170-01-000355.txt#2316 Input fundies:CapitalExpenditure: 6876341 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1018952/0000950170-01-000355.txt#2321 The citation records this snapshot. The page link may show a newer release later.
1999 1999-01-01 – 1999-12-31	−USD 54.55 million Exact value Exact value: -54552227 USD 1999-01-01 – 1999-12-31: -54552227 USD Inspect Net Income Open source Share or cite Citation for Net Income · KOS PHARMACEUTICALS INC · 1999-12-31 KOS PHARMACEUTICALS INC (edgar:1018952) Net Income: -54552227 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1018952/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -54552227 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1018952/0000950144-02-003157.txt#2793 The citation records this snapshot. The page link may show a newer release later.	−USD 51.98 million Exact value Exact value: -51975808 USD 1999-01-01 – 1999-12-31: -51975808 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KOS PHARMACEUTICALS INC · 1999-12-31 KOS PHARMACEUTICALS INC (edgar:1018952) Operating Cash Flow: -51975808 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1018952/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -51975808 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1018952/0000950144-02-003157.txt#2812 The citation records this snapshot. The page link may show a newer release later.	USD 1.12 million Exact value Exact value: 1117637 USD 1999-01-01 – 1999-12-31: 1117637 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · KOS PHARMACEUTICALS INC · 1999-12-31 KOS PHARMACEUTICALS INC (edgar:1018952) Capital Expenditure: 1117637 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1018952/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1117637 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1018952/0000950170-01-000355.txt#2321 The citation records this snapshot. The page link may show a newer release later.	−USD 53.09 million Calculation and evidence -51975808 − 1117637 USD Exact free cash flow: -53093445 USD 1999-01-01 – 1999-12-31: -51975808 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 1117637 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · KOS PHARMACEUTICALS INC · 1999-12-31 KOS PHARMACEUTICALS INC (edgar:1018952) Free cash flow: -53093445 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1018952?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -51975808 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1018952/0000950144-02-003157.txt#2812 Input fundies:CapitalExpenditure: 1117637 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1018952/0000950170-01-000355.txt#2321 The citation records this snapshot. The page link may show a newer release later.
2000 2000-01-01 – 2000-12-31	−USD 35.27 million Exact value Exact value: -35265022 USD 2000-01-01 – 2000-12-31: -35265022 USD Inspect Net Income Open source Share or cite Citation for Net Income · KOS PHARMACEUTICALS INC · 2000-12-31 KOS PHARMACEUTICALS INC (edgar:1018952) Net Income: -35265022 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1018952/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -35265022 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1018952/0000950144-03-003820.txt#7134 The citation records this snapshot. The page link may show a newer release later.	−USD 30.25 million Exact value Exact value: -30253436 USD 2000-01-01 – 2000-12-31: -30253436 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KOS PHARMACEUTICALS INC · 2000-12-31 KOS PHARMACEUTICALS INC (edgar:1018952) Operating Cash Flow: -30253436 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1018952/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -30253436 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1018952/0000950144-03-003820.txt#7463 The citation records this snapshot. The page link may show a newer release later.	USD 638,252 Exact value Exact value: 638252 USD 2000-01-01 – 2000-12-31: 638252 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · KOS PHARMACEUTICALS INC · 2000-12-31 KOS PHARMACEUTICALS INC (edgar:1018952) Capital Expenditure: 638252 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1018952/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 638252 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1018952/0000950170-01-000355.txt#2321 The citation records this snapshot. The page link may show a newer release later.	−USD 30.89 million Calculation and evidence -30253436 − 638252 USD Exact free cash flow: -30891688 USD 2000-01-01 – 2000-12-31: -30253436 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 638252 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · KOS PHARMACEUTICALS INC · 2000-12-31 KOS PHARMACEUTICALS INC (edgar:1018952) Free cash flow: -30891688 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1018952?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -30253436 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1018952/0000950144-03-003820.txt#7463 Input fundies:CapitalExpenditure: 638252 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1018952/0000950170-01-000355.txt#2321 The citation records this snapshot. The page link may show a newer release later.
2001 2001-01-01 – 2001-12-31	USD 2.39 million Exact value Exact value: 2386241 USD 2001-01-01 – 2001-12-31: 2386241 USD Inspect Net Income Open source Share or cite Citation for Net Income · KOS PHARMACEUTICALS INC · 2001-12-31 KOS PHARMACEUTICALS INC (edgar:1018952) Net Income: 2386241 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1018952/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: 2386241 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1018952/0000950144-03-003820.txt#7134 The citation records this snapshot. The page link may show a newer release later.	USD 7.1 million Exact value Exact value: 7102255 USD 2001-01-01 – 2001-12-31: 7102255 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KOS PHARMACEUTICALS INC · 2001-12-31 KOS PHARMACEUTICALS INC (edgar:1018952) Operating Cash Flow: 7102255 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1018952/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 7102255 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1018952/0000950144-03-003820.txt#7463 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2002 2002-01-01 – 2002-12-31	−USD 20.82 million Exact value Exact value: -20816164 USD 2002-01-01 – 2002-12-31: -20816164 USD Inspect Net Income Open source Share or cite Citation for Net Income · KOS PHARMACEUTICALS INC · 2002-12-31 KOS PHARMACEUTICALS INC (edgar:1018952) Net Income: -20816164 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1018952/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -20816164 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1018952/0000950144-05-002605.txt#10888 The citation records this snapshot. The page link may show a newer release later.	−USD 1.24 million Exact value Exact value: -1237038 USD 2002-01-01 – 2002-12-31: -1237038 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KOS PHARMACEUTICALS INC · 2002-12-31 KOS PHARMACEUTICALS INC (edgar:1018952) Operating Cash Flow: -1237038 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1018952/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1237038 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1018952/0000950144-05-002605.txt#11276 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2003 2003-01-01 – 2003-12-31	USD 52.18 million Exact value Exact value: 52178000 USD 2003-01-01 – 2003-12-31: 52178000 USD Inspect Net Income Open source Share or cite Citation for Net Income · KOS PHARMACEUTICALS INC · 2003-12-31 KOS PHARMACEUTICALS INC (edgar:1018952) Net Income: 52178000 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1018952/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: 52178000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1018952/0000950144-06-008796.txt#13633 The citation records this snapshot. The page link may show a newer release later.	USD 55.61 million Exact value Exact value: 55610000 USD 2003-01-01 – 2003-12-31: 55610000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KOS PHARMACEUTICALS INC · 2003-12-31 KOS PHARMACEUTICALS INC (edgar:1018952) Operating Cash Flow: 55610000 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1018952/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 55610000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1018952/0000950144-06-008796.txt#14082 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2004 2004-01-01 – 2004-12-31	USD 144.84 million Exact value Exact value: 144840000 USD 2004-01-01 – 2004-12-31: 144840000 USD Inspect Net Income Open source Share or cite Citation for Net Income · KOS PHARMACEUTICALS INC · 2004-12-31 KOS PHARMACEUTICALS INC (edgar:1018952) Net Income: 144840000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1018952/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: 144840000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1018952/0000950144-06-008796.txt#13633 The citation records this snapshot. The page link may show a newer release later.	USD 196.35 million Exact value Exact value: 196354000 USD 2004-01-01 – 2004-12-31: 196354000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KOS PHARMACEUTICALS INC · 2004-12-31 KOS PHARMACEUTICALS INC (edgar:1018952) Operating Cash Flow: 196354000 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1018952/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 196354000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1018952/0000950144-06-008796.txt#14082 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2005 2005-01-01 – 2005-12-31	USD 114.08 million Exact value Exact value: 114075000 USD 2005-01-01 – 2005-12-31: 114075000 USD Inspect Net Income Open source Share or cite Citation for Net Income · KOS PHARMACEUTICALS INC · 2005-12-31 KOS PHARMACEUTICALS INC (edgar:1018952) Net Income: 114075000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1018952/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: 114075000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1018952/0000950144-06-008796.txt#13633 The citation records this snapshot. The page link may show a newer release later.	USD 237.5 million Exact value Exact value: 237496000 USD 2005-01-01 – 2005-12-31: 237496000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KOS PHARMACEUTICALS INC · 2005-12-31 KOS PHARMACEUTICALS INC (edgar:1018952) Operating Cash Flow: 237496000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1018952/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 237496000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1018952/0000950144-06-008796.txt#14082 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

47 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001018952, 1018952, edgar:1018952

Also known as OPKO HEALTH INC.

KOS PHARMACEUTICALS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Trailing twelve months

Operating cash flow

Capital expenditure

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2005 2005-01-01 – 2005-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation